Vaccine

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales…

1 year ago

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky

$80M investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase production capacity and operational efficiency  Lexington facility…

1 year ago

GHX and Mobile Health Offer Advanced Scheduling for Vendor Compliance

Simplified Process Makes It Easier for Vendor Representatives to Fulfill Lab-based Requirements and Meet Hospitals' Accreditation Guidelines LOUISVILLE, Colo., Sept.…

1 year ago

COVID’s ‘Hidden Figure’ Addresses ‘Techanthropy’ and Small Business Challenges in New Product and National Column

BALTIMORE, MD / ACCESSWIRE / September 30, 2024 / Tiffany Tate, CEO of VAULT Technologies and a recognized leader in…

1 year ago

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the…

1 year ago

Sonnet BioTherapeutics Announces Launch of CEO Corner Platform

CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties…

1 year ago

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional…

1 year ago

POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, is pleased…

1 year ago